Nekton Capital’s CME Group CME Stock Holding History

Nekton Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-129,765	Closed	-$24.9M	–	19
2023 Q1	$24.9M	Sell	129,765 -30,840	-19%	-$5.58M	4.15%	14
2022 Q4	$27M	Buy	+160,605	New	+$27.9M	6.09%	7

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Nekton Capital's CME Position: Q2 2023 in Review

Nekton Capital sold out of CME Group (CME) in Q2 2023, closing a stake of 129,765 shares — an estimated $24.9M sold.

Nekton Capital first reported a position in CME in Q4 2022 and held it in 2 quarters. The position peaked at $27M in Q4 2022. 1,193 funds tracked by Wall St. Rank hold CME as of Q2 2023.

Nekton Capital reported no remaining CME Group position as of Q2 2023 after selling out during the quarter.
Nekton Capital sold 129,765 CME Group shares in Q2 2023, an estimated $24.9M.
Nekton Capital first reported a position in CME Group in Q4 2022 and held it in 2 quarters.
Nekton Capital's CME Group position peaked at $27M in Q4 2022.
1,193 funds tracked by Wall St. Rank held CME Group as of Q2 2023.

Based on Nekton Capital's 13F filing for Q2 2023, filed 14 Aug 2023.